Skip to content

A Study on the Neuroimaging Mechanisms of Hypnotic Drug Addiction in Patients with Chronic Insomnia Combining fMRI and EEG

A Study on the Neuroimaging Mechanisms of Hypnotic Drug Addiction in Patients with Chronic Insomnia Combining fMRI and EEG

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600122012
Enrollment
Unknown
Registered
2026-04-08
Start date
2026-04-24
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Insomnia

Interventions

Hypnotic Drug Addiction Group:None
Non-Addicted Hypnotic Group:None
Healthy Control Group:None

Sponsors

Chengdu Fifth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Sleeping pills group: 1, aged between 18 and 65 years old; 2. Junior high school or above; 3. In accordance with the diagnostic criteria of CID in the International Classification of Sleep Disorders, Third Edition (ICSD-3); Sleep medication use disorder (mainly dependent on benzodiazepines/non-benzodiazepines) was diagnosed by DSM-5. 4. Pittsburgh sleep quality index (PSQI) > 7; 5. Did not participate in other clinical studies 6. Being right-handed. Healthy controls: 1, aged between 18 and 65 years old; 2. Junior high school or above; 3. No complaints of insomnia related symptoms, PSQI total score <5; 4. No neuropsychiatric diseases 5. Being right-handed 6. Keep a regular sleep routine.

Exclusion criteria

Exclusion criteria: 1. History of severe cardiovascular, hepatic, renal, or hematopoietic system diseases; 2. Presence of other sleep disorders such as obstructive sleep apnea, restless legs syndrome, and narcolepsy; history of other neuropsychiatric disorders such as bipolar disorder, major depressive disorder, schizophrenia, or substance abuse; 3. Pregnant or lactating women; 4. Abnormal findings on routine brain MRI examination, such as infarctions or focal lesions; 5. Presence of typical MRI contraindications (e.g., claustrophobia, panic disorder); 6. Shift workers and recent transmeridian travelers;

Design outcomes

Primary

MeasureTime frame
Functional magnetic resonance imaging, fMRI;

Countries

China

Contacts

Public ContactFurong Bai

Chengdu Fifth People's Hospital

953181824@qq.com+86 150 0825 0466

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026